Blonder Tongue Laboratories, Inc. BDRLQ
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -3,576.19% | -180.81% | -- | -- | -- |
| Total Depreciation and Amortization | -21.91% | -10.12% | -- | -- | -- |
| Total Amortization of Deferred Charges | -26.79% | -21.43% | -- | -- | -- |
| Total Other Non-Cash Items | 227.55% | 217.02% | -- | -- | -- |
| Change in Net Operating Assets | 63.11% | 90.07% | -- | -- | -- |
| Cash from Operations | -18.42% | -26.15% | -- | -- | -- |
| Capital Expenditure | -54.84% | -38.46% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.27% | 87.50% | -- | -- | -- |
| Cash from Investing | 36.05% | 35.79% | -- | -- | -- |
| Total Debt Issued | 108.06% | 210.43% | -- | -- | -- |
| Total Debt Repaid | -1,121.31% | -344.27% | -- | -- | -- |
| Issuance of Common Stock | -- | -79.48% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -14.81% | 5.45% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.12% | -153.06% | -- | -- | -- |